Stock fact sheet · data as of
Stryker Corporation (SYK): fair value, margin of safety and Wheel Score
Healthcare · Medical - Devices · United States · Blend
Is SYK undervalued?
At 281.63 (close of 16 Oct 2026), SYK trades 33% over the GLS average fair value of 211.44, with 4 of 9 models above the price. The stock earns none of the Wheel Score's Value points at this price. That is a statement about price against trailing fundamentals, not about the company's prospects - the Wall Street View and the Growth tab on the Quote page carry the forward numbers.
There is a wide gap between DDM (51.79) and Payback Time (363.13). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
The nightly engine files SYK under Blend.
Nine valuation models for SYK
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 288.81 | +3% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 116.98 | -58% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 297.58 | +6% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 110.84 | -61% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 233.70 | -17% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 332.09 | +18% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 363.13 | +29% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | 51.79 | -82% | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend |
| EPV | 108.04 | -62% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | -27.83 | -110% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 365.89 | +30% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Stryker Corporation scores 8 of 9 on the Piotroski F-score, the nine yes/no tests of profitability, leverage and efficiency on the latest annual accounts - a strong reading that passes the Sunday Scan's "6 or more" rule with room to spare. On durability SYK scores 6.9/10 on the GLS Moat - a middle reading; the Scorecard on the Quote page's Financials tab shows which ten-year lines are steady and which are not.
Returns on capital are moderate - ROIC 8.4%, ROE 14.5%, ROA 6.8% - with debt at 0.73 times equity and a free-cash-flow yield of 4.4%.
The dividend yield is 1.25% with a payout ratio of 35% - a small yield that leaves most of the earnings in the business. Revenue comes mainly from Med Surg 55%, Orthopaedics 45% (quarter Q2 FY2026).
Institutional ownership scores 10/10, insider activity 1/10 and Congressional trading 1/10 on the GLS smart-money scales.
| Piotroski F-score | 8 / 9 | ROIC | 8.4% |
|---|---|---|---|
| GLS Moat | 6.9 / 10 | ROE | 14.5% |
| Debt / equity | 0.73 | ROA | 6.8% |
| Free-cash-flow yield | 4.4% | Payout ratio | 35% |
| Institutions | 10 / 10 | Insiders · Congress | 1 · 1 / 10 |
Wheel Score 68: Good
With a Wheel Score of 68 - the Good band - Stryker Corporation falls just short of the Sunday Scan's "70 or higher" rule. The parts: Value 0/25, Health 18/20, Moat 10/15, Premium 20/20, Stability 20/20; Value (0/25) scores lowest.
Implied volatility is 42% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. Chain open interest is 44,920 contracts across all expiries - enough for the wheel at normal size.
Volume runs at 2.2M shares a day on a market cap of $108.0B, with a beta of 0.78 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 20 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 0 / 25 | -33% margin of safety | |
| Health | 18 / 20 | Piotroski 8/9 | |
| Moat | 10 / 15 | moat 6.9/10 | |
| Premium | 20 / 20 | implied volatility 42% | |
| Stability | 20 / 20 | 2.2M shares/day, $108.0B cap, beta 0.78 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
Stryker Corporation reports earnings on 29 Oct 2026 (after the close) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Devices
The 12 companies below are the closest to Stryker Corporation by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| MDT Medtronic Plc | 95.45 | 76.37 | -25% | 64Fair | $122.1B |
| ABT Abbott Laboratories | 104.69 | 67.26 | -56% | 62Fair | $181.2B |
| BSX Boston Scientific Corporation | 44.14 | 65.77 | +33% | 95Prime | $64.0B |
| EW Edwards Lifesciences Corporation | 88.10 | 39.75 | -122% | 62Fair | $50.8B |
| DXCM DexCom, Inc. | 87.71 | 80.03 | -10% | 78Good | $33.1B |
| GEHC GE HealthCare Technologies Inc. | 70.35 | 51.87 | -36% | 58Fair | $31.8B |
| PHG Koninklijke Philips N.V. | 25.00 | 37.85 | +34% | 82Prime | $24.2B |
| ZBH Zimmer Biomet Holdings, Inc. | 91.77 | 134.51 | +32% | 87Prime | $17.5B |
| PEN Penumbra, Inc. | 320.12 | 139.38 | -130% | 54Fair | $12.6B |
| SNN Smith & Nephew plc | 27.88 | 37.94 | +27% | 90Prime | $11.7B |
| ALGN Align Technology, Inc. | 149.34 | 125.50 | -19% | 66Good | $10.6B |
| GMED Globus Medical, Inc. | 78.84 | 112.94 | +30% | 92Prime | $10.6B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about SYK
Is SYK undervalued right now?
No: at 281.63 the stock trades 33% above the GLS average fair value of 211.44 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.
What is the Wheel Score of SYK and what does it mean?
SYK scores 68 out of 100 (Good). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for SYK?
211.44 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Stryker Corporation report earnings next?
The next earnings report is due on 29 Oct 2026 (after the close), 13 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does SYK have listed options, and how liquid are they?
Yes. The nightly snapshot found 672 listed contracts with 44,920 open interest across all expiries and implied volatility of 42% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.